BPG is committed to discovery and dissemination of knowledge
Articles Published Processes Featured Articles Journals Submit a Manuscript
Cited by in CrossRef
For: Colecchia A, Vestito A, Pasqui F, Mazzella G, Roda E, Pistoia F, Brandimarte G, Festi D. Efficacy of long term cyclic administration of the poorly absorbed antibiotic Rifaximin in symptomatic, uncomplicated colonic diverticular disease. World J Gastroenterol 2007; 13(2): 264-269 [PMID: 17226906 DOI: 10.3748/wjg.v13.i2.264]
URL: https://www.wjgnet.com/1007-9327/full/v13/i2/264.htm
(0) (0) (4827) (81)
Number Citing Articles
1
Therapie–Handbuch Innere Medizin Sonderedition 2011⁄2012. 2011;  doi: 10.1016/B978-3-437-22702-8.50009-1
2
Rebecca E. Burgell, Jane G. Muir, Peter R. Gibson. Pathogenesis of Colonic Diverticulosis: Repainting the Picture. Clinical Gastroenterology and Hepatology 2013; 11(12) doi: 10.1016/j.cgh.2013.08.046
3
Samar Ojaima, Tony Korman. Kucers' The Use of Antibiotics Sixth Edition. 2010;  doi: 10.1201/b13787-130
4
Hoonmo L Koo, Herbert L DuPont. Rifaximin: a unique gastrointestinal-selective antibiotic for enteric diseases. Current Opinion in Gastroenterology 2010; 26(1) doi: 10.1097/MOG.0b013e328333dc8d
5
Adi Lahat, Daniela Necula, Miri Yavzori, Orit Picard, Sharon Halperin, Rami Eliakim, Shomron Ben-Horin. Prolonged Recurrent Abdominal Pain is Associated With Ongoing Underlying Mucosal Inflammation in Patients who had an Episode of Acute Complicated Diverticulitis. Journal of Clinical Gastroenterology 2019; 53(5) doi: 10.1097/MCG.0000000000000980
6
Sasan Mosadeghi, Taft Bhuket, Neil Stollman. Diverticular disease. Current Opinion in Gastroenterology 2015; 31(1) doi: 10.1097/MOG.0000000000000145
7
Herbert L DuPont. Biologic properties and clinical uses of rifaximin. Expert Opinion on Pharmacotherapy 2011; 12(2) doi: 10.1517/14656566.2011.546347
8
Veronica Ojetti, Ernesto Cristiano Lauritano, Federico Barbaro, Alessio Migneco, Maria Elena Ainora, Luigi Fontana, Maurizio Gabrielli, Antonio Gasbarrini. Rifaximin pharmacology and clinical implications. Expert Opinion on Drug Metabolism & Toxicology 2009; 5(6) doi: 10.1517/17425250902973695
9
Johann Dréanic, Elena Sion, Marion Dhooge, Bertrand Dousset, Marine Camus, Stanislas Chaussade, Romain Coriat. Traitement de la diverticulite aiguë sigmoïdienne : revue de la littérature. La Presse Médicale 2015; 44(11) doi: 10.1016/j.lpm.2015.08.004
10
Antonio Tursi, Marcello Picchio, Walter Elisei, Francesco Di Mario, Carmelo Scarpignato, Giovanni Brandimarte. Management of Patients With Diverticulosis and Diverticular Disease. Journal of Clinical Gastroenterology 2016; 50(Supplement 1) doi: 10.1097/MCG.0000000000000654
11
Julius Špičák, Miloš Kučera, Gabriela Suchánková. Diverticular disease: diagnosis and treatment. Vnitřní lékařství 2018; 64(6) doi: 10.36290/vnl.2018.086
12
V. Ojetti, G. Gigante, M.E. Ainora, F. Fiore, F. Barbaro, A. Gasbarrini. Microflora imbalance and gastrointestinal diseases. Digestive and Liver Disease Supplements 2009; 3(2) doi: 10.1016/S1594-5804(09)60017-6
13
Edith Lahner, Bruno Annibale. Probiotics, Prebiotics, and Synbiotics. 2016;  doi: 10.1016/B978-0-12-802189-7.00035-6
14
Antonio Tursi. Diverticular disease: A therapeutic overview. World Journal of Gastrointestinal Pharmacology and Therapeutics 2010; 1(1): 27-35 doi: 10.4292/wjgpt.v1.i1.27
15
Melanie Jane Maslow, Cynthia Portal-Celhay. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. 2015;  doi: 10.1016/B978-1-4557-4801-3.00027-8
16
E. V. Golovanova. Cyclic rifaximin and soluble dietary fiber therapy for symptomatic diverticular disease: effective prevention of complications. Medical Council 2019; (3) doi: 10.21518/2079-701X-2019-3-98-107
17
Jasmohan S. Bajaj, Giovanni Barbara, Herbert L. DuPont, F. Mearin, Antonio Gasbarrini, Jan Tack. New concepts on intestinal microbiota and the role of the non-absorbable antibiotics with special reference to rifaximin in digestive diseases. Digestive and Liver Disease 2018; 50(8) doi: 10.1016/j.dld.2018.04.020
18
Marilia Carabotti, Rosario Cuomo, Giovanni Marasco, Giovanni Barbara, Franco Radaelli, Bruno Annibale. Unmet needs in treatment of symptomatic uncomplicated diverticular disease and prevention of recurrent acute diverticulitis: a scoping review. Therapeutic Advances in Gastroenterology 2024; 17 doi: 10.1177/17562848241255297
19
Giovanni Maconi, Giovanni Barbara, Cristina Bosetti, Rosario Cuomo, Bruno Annibale. Treatment of Diverticular Disease of the Colon and Prevention of Acute Diverticulitis: A Systematic Review. Diseases of the Colon & Rectum 2011; 54(10) doi: 10.1097/DCR.0b013e318223cb2b
20
László Lakatos, Péter László Lakatos. Colonic diverticular: disease diagnosis and therapy. Orvosi Hetilap 2012; 153(6) doi: 10.1556/OH.2012.29311
21
M. M. SZOJDA, M. A. CUESTA, C. M. MULDER, R. J. F. FELT‐BERSMA. Review article: management of diverticulitis. Alimentary Pharmacology & Therapeutics 2007; 26(s2) doi: 10.1111/j.1365-2036.2007.03491.x
22
Carmelo Scarpignato, Neil Stollman. Colonic Diverticular Disease. 2022;  doi: 10.1007/978-3-030-93761-4_18
23
Earl R. Gonzales, Karim Alavi. Evaluation and Treatment of Uncomplicated Diverticular Disease. Seminars in Colon and Rectal Surgery 2011; 22(3) doi: 10.1053/j.scrs.2011.05.005
24
Sylvia Stallinger, Norbert Eller, Christoph Högenauer. Non-interventional study evaluating efficacy and tolerability of rifaximin for treatment of uncomplicated diverticular disease. Wiener klinische Wochenschrift 2014; 126(1-2) doi: 10.1007/s00508-013-0447-7
25
Marilia Carabotti, Bruno Annibale, Carola Severi, Edith Lahner. Role of Fiber in Symptomatic Uncomplicated Diverticular Disease: A Systematic Review. Nutrients 2017; 9(2) doi: 10.3390/nu9020161
26
Johann Dréanic, Elena Sion, Marion Dhooge, Bertrand Dousset, Marine Camus, Stanislas Chaussade, Romain Coriat. Traitement de la diverticulite aiguë sigmoïdienne : revue de la littérature. Journal Européen des Urgences et de Réanimation 2016; 28(1) doi: 10.1016/j.jeurea.2016.02.003
27
Anna Pietrzak, Grażyna Rydzewska, Katarzyna Neubauer, Tomasz Banasiewicz, Wiesław Tarnowski. One-year cyclic therapy with rifaximin-α is effective in the treatment of SUDD (Symptomatic Uncomplicated Diverticular Disease) also in patients with a history of complicated diverticulitis. Polish Journal of Surgery 2023; 95(4) doi: 10.5604/01.3001.0053.8079
28
David J. Humes, Robin C. Spiller. Yamada' s Textbook of Gastroenterology. 2015;  doi: 10.1002/9781118512074.ch76
29
Marie-Louise Dichman, Steffen Jais Rosenstock, Daniel M Shabanzadeh. Antibiotics for uncomplicated diverticulitis. Cochrane Database of Systematic Reviews 2022; 2022(6) doi: 10.1002/14651858.CD009092.pub3
30
Neil Stollman, Simon Magowan, Fergus Shanahan, Eamonn M.M. Quigley. A Randomized Controlled Study of Mesalamine After Acute Diverticulitis. Journal of Clinical Gastroenterology 2013; 47(7) doi: 10.1097/MCG.0b013e31828003f6
31
Guy W. Neff, Michael Jones, Taylor Broda, Mark Jonas, Ravinuthala Ravi, David Novick, Tiffany E. Kaiser, Nyingi Kemmer. Durability of Rifaximin Response in Hepatic Encephalopathy. Journal of Clinical Gastroenterology 2012; 46(2) doi: 10.1097/MCG.0b013e318231faae
32
L. Daniels, A. E. Budding, N. de Korte, A. Eck, J. A. Bogaards, H. B. Stockmann, E. C. Consten, P. H. Savelkoul, M. A. Boermeester. Fecal microbiome analysis as a diagnostic test for diverticulitis. European Journal of Clinical Microbiology & Infectious Diseases 2014; 33(11) doi: 10.1007/s10096-014-2162-3
33
Lisa L. Strate, Anne F. Peery, Ignacio Neumann. American Gastroenterological Association Institute Technical Review on the Management of Acute Diverticulitis. Gastroenterology 2015; 149(7) doi: 10.1053/j.gastro.2015.10.001
34
N. V. Orlova, D. V. Lukanin. Diverticular disease of colon. Unresolved issues. Medical alphabet 2019; 2(27) doi: 10.33667/2078-5631-2019-2-27(402)-26-31
35
Mariam N. Hantouli, David J. Droullard, Lisa L. Strate, David R. Flum, Erika M. Wolff, Mukta K. Krane, Diana K.N. Louden, Giana H. Davidson. Optimizing medical management for diverticular disease: A systematic review and gap analysis. Seminars in Colon and Rectal Surgery 2020; 31(4) doi: 10.1016/j.scrs.2020.100782
36
Eleonora Scaioli, Antonio Colecchia, Giovanni Marasco, Ramona Schiumerini, Davide Festi. Pathophysiology and Therapeutic Strategies for Symptomatic Uncomplicated Diverticular Disease of the Colon. Digestive Diseases and Sciences 2016; 61(3) doi: 10.1007/s10620-015-3925-0
37
Antonio Tursi, Giovanni Brandimarte, Francesco Di Mario, Wenjie Ma, Juozas Kupcinskas, Jaroslaw Regula, Giovanni Maconi, Peter Malfertheiner, Giovanni Barbara, Neil Stollman, Savvas Papagrigoriadis, Thomas Golda, Antonio Amato, Mauro Bafutto, Gabrio Bassotti, Gian A Binda, Sebastiano Biondo, Pellegrino Crafa, Dan Dumitrascu, Walter Elisei, Nicola Flor, Kok Ann Gwee, David James Humes, Takaomi Kessoku, Wolfgang Kruis, Adi Lahat, Angel Lanas, Atsushi Nakajima, Marcello Picchio, Robin C Spiller, Athena Adamopoulos, Carmelo Scarpignato. Global guidelines on diverticular disease of the colon: the Fiesole Consensus report. Gut 2025;  doi: 10.1136/gutjnl-2025-336902
38
Lukasz Krokowicz, Zoran Stojcev, Bartosz Filip Kaczmarek, Wojciech Kociemba, Elżbieta Kaczmarek, Jaroslaw Walkowiak, Piotr Krokowicz, Michal Drews, Tomasz Banasiewicz. Microencapsulated sodium butyrate administered to patients with diverticulosis decreases incidence of diverticulitis—a prospective randomized study. International Journal of Colorectal Disease 2014; 29(3) doi: 10.1007/s00384-013-1807-5
39
Loai Albarqouni, Yousuf El Mokhallalati, Mohammad JH Elhissi, Said Alyacoubi, Sobhi Skaik, Khamis Elessi, Rahul Kumar, Balendra P Singh, Vijay Kumar. Prophylactic antibiotics for preventing recurrent symptomatic episodes of acute diverticulitis. Cochrane Database of Systematic Reviews 2013;  doi: 10.1002/14651858.CD010635
40
Wen Boynton, Martin Floch. New strategies for the management of diverticular disease: insights for the clinician. Therapeutic Advances in Gastroenterology 2013; 6(3) doi: 10.1177/1756283X13478679
41
Timothy J. Ness, L. Vandy Black. Evidence‐Based Chronic Pain Management. 2010;  doi: 10.1002/9781444314380.ch15
42
A. Tursi, A. Papa, S. Danese. Review article: the pathophysiology and medical management of diverticulosis and diverticular disease of the colon. Alimentary Pharmacology & Therapeutics 2015; 42(6) doi: 10.1111/apt.13322
43
Chirag D. Trivedi, Kiron M. Das. Emerging Therapies for Diverticular Disease of the Colon. Journal of Clinical Gastroenterology 2008; 42(10) doi: 10.1097/MCG.0b013e318188adc1
44
Davide Festi, Antonio Colecchia. Mesalazine and Rifaximin in Symptomatic Uncomplicated Diverticular Disease. The American Journal of Gastroenterology 2009; 104(2) doi: 10.1038/ajg.2008.53
45
A. TURSI, S. PAPAGRIGORIADIS. Review article: the current and evolving treatment of colonic diverticular disease. Alimentary Pharmacology & Therapeutics 2009; 30(6) doi: 10.1111/j.1365-2036.2009.04072.x
46
A. Colecchia, D. Festi, E. Scaioli, V. Ruggiero, M. Berardino, P. Portincasa. Bacterial flora, gas and antibiotics. Digestive and Liver Disease Supplements 2009; 3(2) doi: 10.1016/S1594-5804(09)60021-8
47
O. S. Shifrin, E. A. Poluektova, A. V. Korolev, T. I. Semenova, M. V. Shein, G. N. Leksikova, O. A. Tokareva, O. E. Davydova, P. S. Andreev, S. E. Katorkin, A. A. Chernov, A. V. Zhuravlev, O. S. Sek, A. A. Kopina, N. Yu. Samokhina, Yu. V. Gorozhankina, M. F. Samigullin, V. S. Groshilin, E. N. Borisova, T. A. Petrova, I. Yu. Pirogova, S. V. Mednikov, N. V. Smagin, A. S. Sarsenbaeva, N. V. Smirnova, L. G. Kirsanova, N. M. Malyutina, M. A. Smirnova, E. N. Shleikova, V. T. Ivashkin. Russian Non-Interventional Study of the Efficacy and Tolerability of Rifaximin-α Therapy in Patients with Uncomplicated Diverticular Disease under the Conditions of Outpatient Practice. Russian Journal of Gastroenterology, Hepatology, Coloproctology 2020; 30(1) doi: 10.22416/1382-4376-2020-30-1-14-25
48
Iain O’Neill. A Worldwide Perspective on Diagnosis and Management of Diverticular Disease: Understanding Similarities and Differences. EMJ Gastroenterology 2018;  doi: 10.33590/emjgastroenterol/10311869
49
Maurizio Koch, Alberto Enrico Maraolo, Giuseppe Natoli, Salvatore Corrao. Preventing acute diverticulitis. any roles for non-absorbable antibiotics? in search of evidence: a systematic review, meta-analysis, and trial sequential analysis. Frontiers in Gastroenterology 2023; 2 doi: 10.3389/fgstr.2023.1170271
50
Camilla Ritieni, Caterina Sbarigia, Silvia Scalamonti, Bruno Annibale, Marilia Carabotti. Symptomatic uncomplicated diverticular disease: a critical appraisal. Expert Review of Gastroenterology & Hepatology 2024; 18(7) doi: 10.1080/17474124.2024.2388797
51
Adi Lahat, Herma H Fidder, Shomron Ben-Horin. Development and validation of a diverticular clinical score for symptomatic uncomplicated diverticular disease after acute diverticulitis in a prospective patient cohort. Therapeutic Advances in Gastroenterology 2020; 13 doi: 10.1177/1756284820913210
52
Mona Rezapour, Neil Stollman. Management of Diverticulosis. Current Treatment Options in Gastroenterology 2021; 19(1) doi: 10.1007/s11938-020-00329-4
53
Giovanni Latella, Carmelo Scarpignato. Rifaximin in the management of colonic diverticular disease. Expert Review of Gastroenterology & Hepatology 2009; 3(6) doi: 10.1586/egh.09.63
54
The Dentist's Quick Guide to Medical Conditions. 2015;  doi: 10.1002/9781118991473.ch1
55
Angel Lanas, Julio Ponce, Angelo Bignamini, Fermín Mearin. One year intermittent rifaximin plus fibre supplementation vs. fibre supplementation alone to prevent diverticulitis recurrence: A proof-of-concept study. Digestive and Liver Disease 2013; 45(2) doi: 10.1016/j.dld.2012.09.006
56
Riccardo Urgesi, Cristiano Pagnini, Fernando De Angelis, Amjad Khan, Lorella Pallotta, Gianfranco Fanello, Pavlos Antypas, Maria Carla Di Paolo, Giuseppe Villotti, Alexander Bertuccioli, Davide Sisti, Francesco Di Pierro, Nicola Zerbinati, Maria Giovanna Graziani. Management of symptomatic uncomplicated diverticular disease (SUDD) of the colon with Clostridium butyricum CBM588 versus rifaximin: a retrospective cross-sectional study. International Journal of Colorectal Disease 2025; 40(1) doi: 10.1007/s00384-025-05005-6
57
Stéphane M. Schneider, Sarah Giudicelli. Probiotiques Et Autres Pathologies Digestives : Perspectives. Cahiers de Nutrition et de Diététique 2007; 42 doi: 10.1016/S0007-9960(07)91323-1
58
Carla J. Gargallo Puyuelo, Federico Sopeña, Angel Lanas Arbeloa. Colonic diverticular disease. Treatment and prevention. Gastroenterología y Hepatología 2015; 38(10) doi: 10.1016/j.gastrohep.2015.03.010
59
T. Pohle, W. Domschke, C. Reißfelder, B. Schmied, M.W. Büchler. Therapie-Handbuch Grundwerk inkl 6. Lfg.. 2015;  doi: 10.1016/B978-3-437-22107-1.50179-5
60
Anna Piccin, Marco Gulotta, Stefano di Bella, Paola Martingano, Lory Saveria Crocè, Mauro Giuffrè. Diverticular Disease and Rifaximin: An Evidence-Based Review. Antibiotics 2023; 12(3) doi: 10.3390/antibiotics12030443
61
Antonio Tursi. Preventing recurrent acute diverticulitis with pharmacological therapies. Therapeutic Advances in Chronic Disease 2013; 4(6) doi: 10.1177/2040622313498809
62
Rosario Cuomo, Giovanni Barbara, Bruno Annibale. Rifaximin and diverticular disease: Position paper of the Italian Society of Gastroenterology (SIGE). Digestive and Liver Disease 2017; 49(6) doi: 10.1016/j.dld.2017.01.164
63
Federico Sopeña, Angel Lanas. Management of colonic diverticular disease with poorly absorbed antibiotics and other therapies. Therapeutic Advances in Gastroenterology 2011; 4(6) doi: 10.1177/1756283X11412820
64
Giovanni Marasco, Francesco Buttitta, Cesare Cremon, Maria Raffaella Barbaro, Vincenzo Stanghellini, Giovanni Barbara. The role of microbiota and its modulation in colonic diverticular disease. Neurogastroenterology & Motility 2023; 35(12) doi: 10.1111/nmo.14615
65
M. Bianchi, V. Festa, A. Moretti, A. Ciaco, M. Mangone, V. Tornatore, A. Dezi, R. Luchetti, B. De Pascalis, C. Papi, M. Koch. Meta-analysis: long-term therapy with rifaximin in the management of uncomplicated diverticular disease. Alimentary Pharmacology & Therapeutics 2011; 33(8) doi: 10.1111/j.1365-2036.2011.04606.x
66
Rosario Cuomo, Giovanni Barbara, Fabio Pace, Vito Annese, Gabrio Bassotti, Gian Andrea Binda, Tino Casetti, Antonio Colecchia, Davide Festi, Roberto Fiocca, Andrea Laghi, Giovanni Maconi, Riccardo Nascimbeni, Carmelo Scarpignato, Vincenzo Villanacci, Bruno Annibale. Italian consensus conference for colonic diverticulosis and diverticular disease. United European Gastroenterology Journal 2014; 2(5) doi: 10.1177/2050640614547068
67
Akira Mizuki, Masayuki Tatemichi, Atsushi Nakazawa, Nobuhiro Tsukada, Hiroshi Nagata, Yoshikazu Kinoshita. Effects of Burdock tea on recurrence of colonic diverticulitis and diverticular bleeding: An open-labelled randomized clinical trial. Scientific Reports 2019; 9(1) doi: 10.1038/s41598-019-43236-0
68
Keta K. Vaidya, Martin H. Floch. Diverticular Disease: Paradigm Shifts in Pathogenesis and Treatment. Current Treatment Options in Gastroenterology 2015; 13(1) doi: 10.1007/s11938-014-0045-4
69
G. A. Binda, R. Cuomo, A. Laghi, R. Nascimbeni, A. Serventi, D. Bellini, P. Gervaz, B. Annibale. Practice parameters for the treatment of colonic diverticular disease: Italian Society of Colon and Rectal Surgery (SICCR) guidelines. Techniques in Coloproctology 2015; 19(10) doi: 10.1007/s10151-015-1370-x
70
Francesco Di Mario, Chiara Miraglia, Ginevra Cambiè, Alessandra Violi, Antonio Nouvenne, Marilisa Franceschi, Giovanni Brandimarte, Walter Elisei, Marcello Picchio, Antonio Tursi. Long-term efficacy of rifaximin to manage the symptomatic uncomplicated diverticular disease of the colon. Journal of Investigative Medicine 2019; 67(4) doi: 10.1136/jim-2018-000901
71
Jeannette Y. Wick. Diverticular Disease: Eat Your Fiber!. The Consultant Pharmacist 2012; 27(9) doi: 10.4140/TCP.n.2012.613
72
Lino Polese, Alice Bressan, Edoardo Savarino, Massimo Vecchiato, Angelo Turoldo, Annachiara Frigo, Giacomo Carlo Sturniolo, Nicolò De Manzini, Roberto Petri, Stefano Merigliano. Quality of life after laparoscopic sigmoid resection for uncomplicated diverticular disease. International Journal of Colorectal Disease 2018; 33(5) doi: 10.1007/s00384-018-3005-y
73
Alba Rocco, Debora Compare, Flora Caruso, Gerardo Nardone. Treatment Options for Uncomplicated Diverticular Disease of the Colon. Journal of Clinical Gastroenterology 2009; 43(9) doi: 10.1097/MCG.0b013e3181b3ab2e
74
Jeffrey M. Fox, Neil H. Stollman. Sleisenger and Fordtran's Gastrointestinal and Liver Disease. 2010;  doi: 10.1016/B978-1-4160-6189-2.00117-7
75
Francesca Romana Ponziani, Viviana Gerardi, Silvia Pecere, Francesca D’Aversa, Loris Lopetuso, Maria Assunta Zocco, Maurizio Pompili, Antonio Gasbarrini. Effect of rifaximin on gut microbiota composition in advanced liver disease and its complications. World Journal of Gastroenterology 2015; 21(43): 12322-12333 doi: 10.3748/wjg.v21.i43.12322
76
Jason Hemming, Martin Floch. Features and Management of Colonic Diverticular Disease. Current Gastroenterology Reports 2010; 12(5) doi: 10.1007/s11894-010-0126-z
77
Giacomo Calini, Mohamed A Abd El Aziz, Lucia Paolini, Solafah Abdalla, Matteo Rottoli, Giulio Mari, David W Larson. Symptomatic Uncomplicated Diverticular Disease (SUDD): Practical Guidance and Challenges for Clinical Management. Clinical and Experimental Gastroenterology 2023;  doi: 10.2147/CEG.S340929
78
Rohin Mittal, Tan Arulampalam. Diverticulitis. 2026;  doi: 10.1007/978-3-032-21720-2_14
79
Alberto Lué, Viviana Laredo, Angel Lanas. Medical Treatment of Diverticular Disease. Journal of Clinical Gastroenterology 2016; 50(Supplement 1) doi: 10.1097/MCG.0000000000000593
80
Antonietta Gerarda Gravina, Raffaele Pellegrino, Salvatore Auletta, Giovanna Palladino, Giovanni Brandimarte, Rossella D’Onofrio, Giusi Arboretto, Giuseppe Imperio, Andrea Ventura, Marina Cipullo, Marco Romano, Alessandro Federico. <i>Hericium erinaceus</i>, a medicinal fungus with a centuries-old history: Evidence in gastrointestinal diseases. World Journal of Gastroenterology 2023; 29(20): 3048-3065 doi: 10.3748/wjg.v29.i20.3048
81
Francesca Romana Ponziani, Franco Scaldaferri, Valentina Petito, Francesco Paroni Sterbini, Silvia Pecere, Loris R. Lopetuso, Alessandra Palladini, Viviana Gerardi, Luca Masucci, Maurizio Pompili, Giovanni Cammarota, Maurizio Sanguinetti, Antonio Gasbarrini. The Role of Antibiotics in Gut Microbiota Modulation: The Eubiotic Effects of Rifaximin. Digestive Diseases 2016; 34(3) doi: 10.1159/000443361
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.